231 related articles for article (PubMed ID: 11350956)
1. The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2.
Odermatt A; Arnold P; Frey FJ
J Biol Chem; 2001 Jul; 276(30):28484-92. PubMed ID: 11350956
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of nuclear 11beta-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues.
Petrelli MD; Lim-Tio SS; Condon J; Hewison M; Stewart PM
Endocrinology; 1997 Jul; 138(7):3077-80. PubMed ID: 9202257
[TBL] [Abstract][Full Text] [Related]
3. 11β-HSD2 SUMOylation Modulates Cortisol-Induced Mineralocorticoid Receptor Nuclear Translocation Independently of Effects on Transactivation.
Jiménez-Canino R; Lorenzo-Díaz F; Odermatt A; Bailey MA; Livingstone DEW; Jaisser F; Farman N; Alvarez de la Rosa D
Endocrinology; 2017 Nov; 158(11):4047-4063. PubMed ID: 28938454
[TBL] [Abstract][Full Text] [Related]
4. The role of 11beta-hydroxysteroid dehydrogenase in steroid hormone specificity.
Náray-Fejes-Tóth A; Colombowala IK; Fejes-Tóth G
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):311-6. PubMed ID: 9699885
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of the type 2 11beta-hydroxysteroid dehydrogenase. A green fluorescent protein study.
Náray-Fejes-Tóth A; Fejes-Tóth G
J Biol Chem; 1996 Jun; 271(26):15436-42. PubMed ID: 8663122
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane.
Odermatt A; Arnold P; Stauffer A; Frey BM; Frey FJ
J Biol Chem; 1999 Oct; 274(40):28762-70. PubMed ID: 10497248
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
Stewart PM
Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
9. Human 11 beta-hydroxysteroid dehydrogenase: studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue.
Bujalska I; Shimojo M; Howie A; Stewart PM
Steroids; 1997 Jan; 62(1):77-82. PubMed ID: 9029719
[TBL] [Abstract][Full Text] [Related]
10. LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors.
Leckie C; Chapman KE; Edwards CR; Seckl JR
Endocrinology; 1995 Dec; 136(12):5561-9. PubMed ID: 7588309
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenase 2 in human gastric mucosa.
Kato K; Sasano H; Ohara S; Sekine H; Mochizuki S; Mune T; Yasuda K; Nagura H; Shimosegawa T; Toyota T; Krozowski Z
J Clin Endocrinol Metab; 1999 Jul; 84(7):2568-73. PubMed ID: 10404838
[TBL] [Abstract][Full Text] [Related]
12. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
Ricketts ML; Stewart PM
Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
[TBL] [Abstract][Full Text] [Related]
13. Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis.
Quattropani C; Vogt B; Odermatt A; Dick B; Frey BM; Frey FJ
J Clin Invest; 2001 Nov; 108(9):1299-305. PubMed ID: 11696574
[TBL] [Abstract][Full Text] [Related]
14. Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesis.
Morris DJ; Brem AS; Odermatt A
J Steroid Biochem Mol Biol; 2021 Nov; 214():105988. PubMed ID: 34464733
[TBL] [Abstract][Full Text] [Related]
15. Prereceptor regulation of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation.
Rabbitt EH; Lavery GG; Walker EA; Cooper MS; Stewart PM; Hewison M
FASEB J; 2002 Jan; 16(1):36-44. PubMed ID: 11772934
[TBL] [Abstract][Full Text] [Related]
16. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line.
Darnel AD; Archer TK; Yang K
J Steroid Biochem Mol Biol; 1999; 70(4-6):203-10. PubMed ID: 10622409
[TBL] [Abstract][Full Text] [Related]
17. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension.
Hatakeyama H; Inaba S; Miyamori I
Hypertension; 1999 May; 33(5):1179-84. PubMed ID: 10334808
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.
Frey FJ; Odermatt A; Frey BM
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):451-8. PubMed ID: 15199296
[TBL] [Abstract][Full Text] [Related]
19. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
Morris DJ; Latif SA; Hardy MP; Brem AS
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
[TBL] [Abstract][Full Text] [Related]
20. Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor.
Stauffer AT; Rochat MK; Dick B; Frey FJ; Odermatt A
J Biol Chem; 2002 Jul; 277(29):26286-92. PubMed ID: 12015312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
